GGrantIndex
← Search

Imaging Core

$177,741P30FY2012CANIH

University Of Arizona, Tucson AZ

Investigators

Linked publications, trials & patents

Paper 39631050Paper 39622842Paper 39612086Paper 39361227Paper 39312766Paper 39151774Paper 39100646Paper 39075233Paper 38875929Paper 38858600Paper 38826434Paper 38804255Paper 38769192Paper 38759377Paper 38729260Paper 38719743Paper 38715255Paper 38687603Paper 38658768Paper 38639990Paper 38613866Paper 38612480Paper 38474232Paper 38464045Paper 38453918Paper 38386696Paper 38386396Paper 38328594Paper 38313301Paper 38309054Paper 38291312Paper 38215755Paper 38203706Paper 38199366Paper 38164625Paper 38164604Paper 38097734Paper 38097593Paper 38096366Trial NCT07214506Trial NCT06009926Trial NCT05699603Trial NCT05237960Trial NCT05121051Trial NCT04530552Trial NCT03708055Trial NCT03602066Trial NCT03601507Trial NCT03578432Trial NCT03422536Trial NCT03402230Trial NCT03376971Trial NCT03365895Trial NCT03196180Trial NCT02581137Trial NCT02568566Trial NCT02348203Trial NCT02326805Trial NCT02123849Trial NCT01686165Trial NCT01433913Trial NCT01394211Trial NCT01385280Trial NCT01370889Trial NCT01288261Trial NCT01172028Trial NCT01097304Trial NCT01077453Trial NCT00980395Trial NCT00978718Trial NCT00900432Trial NCT00900341Trial NCT00898703Trial NCT00896935Trial NCT00892268Trial NCT00841204Trial NCT00752739Trial NCT00732498Trial NCT00721877Trial NCT00702299Trial NCT00701857Trial NCT00699907Trial NCT00619060Trial NCT00608634Trial NCT00601640Trial NCT00410618Trial NCT00373022Trial NCT00363805Trial NCT00303823Trial NCT00245024Trial NCT00091325Trial NCT00078897Trial NCT00003307Trial NCT00003082Patent 9486545Patent 9435812Patent 9415110Patent 9262824Patent 5650489Patent 5510240

Abstract

9.1.7 IMAGING CORE SHARED SERVICE The Cancer Center and affiliated programs house equipment and expertise in the development and application of a variety of in vivo imaging modilities including PET/SPECT, MR and optical approaches to in vivo imaging. The mission of the Imaging Core service is to provide Cancer Center members easy access to these state-of-the art in vivo imaging capabilities. Within this context, the Imaging Core provides three specific services to the Cancer Center members. An Institutional Imaging Advisory Committee provides a mechanism through which investigators may initiate projects, have them critically reviewed and facilitate access to appropriate image acquisition modalities. Optical imaging capabilities in confocal imaging, bioluminescence analysis of gene expression, and confocal endoscopy and spectroscopy are provided. The Core also provides access to technical expertise for operating and analyzing data acquired for pre-clinical MRI, PET/SPECT, and OCT, as well as. Clinical MRI approaches. A second area of focus, the Core is responsible for developing standardized platforms for image analysis housed in a centralized facility where experts in image processing and development of custom analysis algorithms are consolidated. The image processing facility, housed in the MRB, provides access to high end graphics computing capabilities, and experts who can provide both basic training and advice in image analysis approaches, as well as expertise to develop and customize specific image processing techniques. Thirdly, the Imaging Response Assessment Team (IRAT) has been incorporated into the ICSS for this renewal. The goal of this program is to increase the use of functional and molecular imaging endpoints as biomarkers in clinical drug trials. As such, all protocols initiated by AZCC investigators are vetted by the IRAT committee, who provide documented suggestions for inclusion of imaging endpoints. Consequently, the IRAT at AZCC will strictly conform to the ideals and concepts of the IRAT program and is committed to participating in the national consortium of IRATs focused on the use of quantitative imaging in clinical trials.

View original record on NIH RePORTER →